G3BP1/2-Targeting PROTAC Disrupts Stress Granules Dependent ATF4 Migracytosis as Cancer Therapy DOI
Ting Dong, Fabao Zhao,

Mengmeng Wang

et al.

Journal of the American Chemical Society, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 22, 2024

Stress granules (SGs) are membraneless cytoplasmic compartments that form in response to stress stimuli. In these compartments, most translation factors stall, except for activating transcription factor 4 (ATF4), which is preferentially translated ensure cell survival under stressful conditions. Cancer cells encounter various conditions the tumor microenvironment during tumorigenesis; however, how they exploit pro-survival effects of ATF4 SGs remains unclear. G3BP1/2 central nodes SG network, regulating dynamics. this study, we designed two small molecules, #129 and PROTAC (Proteolysis Targeting Chimera) degrader 129 (PT-129), specifically target NTF2L domain G3BP1/2, a crucial hub protein RNA interactions. These compounds inhibit formation stressed disassemble pre-existing granules. Furthermore, pharmacological inhibition by PT-129 suppressed fibroblast-mediated cancer growth vitro reduced vivo. Mechanistically, facilitates delivery from fibroblasts via migracytosis, primary mediator fibroblast-associated growth. PT-129-mediated disassembly disrupts delivery, thereby preventing proliferation. compounds, therefore, represent powerful tools gaining molecular insights into hold promise therapeutic interventions modulating granule

Language: Английский

Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2) DOI Open Access
Natalia V. Ortiz Zacarı́as, Sascha Röth, Jeremy D. Broekhuis

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(16), P. 8984 - 8984

Published: Aug. 18, 2024

CC chemokine receptor 2 (CCR2) has been linked to many inflammatory and immune diseases, making it a relevant drug target. Yet, all CCR2 antagonists developed so far have failed in clinical trials; thus, novel strategies are needed target this receptor. Targeted protein degradation represents approach inhibit function by hijacking the cellular machinery, such as proteasome, degrade of interest. Here, we aimed determine amenability chemically induced using fusion containing HaloTag7 HiBiT tag (CCR2-HaloTag-HiBiT). After characterization construct, used luminescence-based assays immunofluorescence quantify levels, well label-free, phenotypic assay investigate functional effect degradation. Treatment with HaloPROTAC3, which selectively degrades HaloTag proteins, led concentration- time-dependent CCR2-HaloTag-HiBiT. HaloPROTAC3 via was fully blocked proteasomal inhibitors. Finally, showed that CCR2-HaloTag-HiBiT leads reduced response after agonist stimulation. Overall, our results indicate is amenable targeted degradation, paving way for future development chemical degraders.

Language: Английский

Citations

1

To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives DOI

Diana Castagna,

Benoit Gourdet,

Roland Hjerpe

et al.

Progress in medicinal chemistry, Journal Year: 2024, Volume and Issue: unknown, P. 61 - 160

Published: Jan. 1, 2024

Language: Английский

Citations

1

A Self-Assembled Nano-Molecular Glue (Nano-mGlu) Enables GSH/H2O2-Triggered Targeted Protein Degradation in Cancer Therapy DOI
Jie Sun,

Mingxi Gu,

Liang Peng

et al.

Journal of the American Chemical Society, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 20, 2024

Molecular glues are promising protein-degrading agents that hold great therapeutic potential but face significant challenges in rational design, effective synthesis, and precise targeting of tumor sites. In this study, we first overcame some these limitations by introducing a fumarate-based molecular glue handle onto specific ligands kinases (TBK1, FGFR, Bcr-Abl), resulting the degradation important cancer targets. Despite broad applicability strategy, unexpectedly discovered potent widespread cytotoxicity across various cell lines, including noncancerous ones, rendering it less therapy. To address critical issue, next developed self-assembled nanoparticle-based (nano-mGlu) based on one newly Bcr-Abl-degrading (H1-mGlu). We showed nano-mGlu (named Cle-NP) was able to release H1-mGlu vitro presence high concentration GSH or H2O2 (commonly found microenvironment). Subsequent vivo antitumor studies with K562-xenografted mouse model indicated Cle-NP highly tumor-specific endogenous Bcr-Abl expressed K562 cells, leading eventual regression while maintaining good biosafety profiles. With key advantages generality targeted delivery (e.g., H1-mGlu), activity partially induced target-specific degradation, minimized collateral damage healthy tissues, our strategy thus provides novel approach might promise for personalized

Language: Английский

Citations

1

G3BP1/2-Targeting PROTAC Disrupts Stress Granules Dependent ATF4 Migracytosis as Cancer Therapy DOI
Ting Dong, Fabao Zhao,

Mengmeng Wang

et al.

Journal of the American Chemical Society, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 22, 2024

Stress granules (SGs) are membraneless cytoplasmic compartments that form in response to stress stimuli. In these compartments, most translation factors stall, except for activating transcription factor 4 (ATF4), which is preferentially translated ensure cell survival under stressful conditions. Cancer cells encounter various conditions the tumor microenvironment during tumorigenesis; however, how they exploit pro-survival effects of ATF4 SGs remains unclear. G3BP1/2 central nodes SG network, regulating dynamics. this study, we designed two small molecules, #129 and PROTAC (Proteolysis Targeting Chimera) degrader 129 (PT-129), specifically target NTF2L domain G3BP1/2, a crucial hub protein RNA interactions. These compounds inhibit formation stressed disassemble pre-existing granules. Furthermore, pharmacological inhibition by PT-129 suppressed fibroblast-mediated cancer growth vitro reduced vivo. Mechanistically, facilitates delivery from fibroblasts via migracytosis, primary mediator fibroblast-associated growth. PT-129-mediated disassembly disrupts delivery, thereby preventing proliferation. compounds, therefore, represent powerful tools gaining molecular insights into hold promise therapeutic interventions modulating granule

Language: Английский

Citations

0